INGN Inogen Inc
Price Chart
Executive Summary
Inogen shareholders approved the Amended and Restated 2023 Equity Incentive Plan at the annual meeting on June 5, 2026, increasing the share reserve by 750,000 shares. Routine governance update with no material financial impact.
Actionable Insight
This is a routine administrative filing from the annual meeting. No immediate trading action warranted. Monitor future equity grant disclosures for potential dilution impact.
Key Facts
- Shareholders approved the Amended and Restated 2023 Equity Incentive Plan with 16,208,966 votes for, 2,009,937 against, and 54,322 abstentions
- The plan amendment adds 750,000 shares to the equity incentive pool
- Class III directors Glenn Boehnlein and Mira Sahney were elected
- Deloitte & Touche LLP ratified as auditor for FY2026
- Advisory vote on executive compensation passed with 17,316,134 votes for
- Proposal to declassify the board did not pass (17,883,761 for, but required supermajority under existing charter)
- Approximately 76.28% of outstanding shares were represented at the meeting
Financial Impact
Dilution of approximately 2.7% from 750,000 additional shares authorized under the equity plan
Risk Factors
- Potential dilution from future equity grants under the expanded plan
- Board declassification failure may signal governance concerns to some investors
Market Snapshot
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001294133-26-000021 |
| Document: ingn-ex10_4.htm | 0001294133-26-000021 |
| Document: ingn-ex10_3.htm | 0001294133-26-000021 |
| Document: ingn-ex10_2.htm | 0001294133-26-000021 |
| Document: ingn-20260605.htm | 0001294133-26-000021 |
| Document: 0001294133-26-000021-index-headers.html | 0001294133-26-000021 |
| Document: 0001294133-26-000021-index.html | 0001294133-26-000021 |
| Document: 0001294133-26-000021.txt | 0001294133-26-000021 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
8-K
| $6.30 awaiting T+20 | awaiting T+20 | — | $6.40 (+1.59%) |
|
Apr 6, 2026
9w ago
|
8-K
| $6.80 $6.97 | ▲ +2.50% | ▼ −7.28% | $6.40 (−5.88%) |
|
Feb 24, 2026
15w ago
|
8-K
| $6.01 $6.42 | ▲ +6.82% | ▲ +12.06% | $6.40 (+6.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access